Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Implementation of an ST-Segment Elevation Myocardial Infarction Bypass Protocol in the Northern United Arab Emirates.

Batt AM, Al-Hajeri AS, Delport S, Jenkins SM, Norman SE, Cummins FH.

Heart Views. 2018 Oct-Dec;19(4):121-127. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_81_17.

2.

#FOAMems: Engaging paramedics with free, online open-access education.

Mason P, Batt AM.

J Educ Health Promot. 2018 Mar 1;7:32. doi: 10.4103/jehp.jehp_84_17. eCollection 2018.

3.

Urgent Need to Strengthen the Chain of Survival in the United Arab Emirates; a Letter to the Editor.

Batt AM, Mohamed Al-Hajeri AS, Cummins FH.

Emerg (Tehran). 2017;5(1):e51. Epub 2017 Jan 14. No abstract available.

4.

A profile of out-of-hospital cardiac arrests in Northern Emirates, United Arab Emirates.

Batt AM, Al-Hajeri AS, Cummins FH.

Saudi Med J. 2016 Nov;37(11):1206-1213. doi: 10.15537/smj.2016.11.16126.

5.

Out of hospital adult cardiac arrests in a university hospital in Central Saudi Arabia.

Batt AM, Al-Hajeri AS, Cummins FH, Bin Salleeh H.

Saudi Med J. 2016 Jun;37(6):714. doi: 10.15537/Smj.2016.6.14852.

6.

Do Paramedics Have a Role to Play in Organ Donation?

Batt AM, Tomkinson CB, Morgan L, Norman S.

Transplantation. 2016 Aug;100(8):e42-3. doi: 10.1097/TP.0000000000001212. No abstract available.

PMID:
27257996
7.

Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase.

Gueguen Y, Ferrari L, Souidi M, Batt AM, Lutton C, Siest G, Visvikis S.

Basic Clin Pharmacol Toxicol. 2007 Jun;100(6):392-7.

8.

Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.

Bertrand-Thiebault C, Masson C, Siest G, Batt AM, Visvikis-Siest S.

J Cardiovasc Pharmacol. 2007 May;49(5):306-15.

PMID:
17513950
9.

[Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs].

Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

Ann Pharm Fr. 2007 May;65(3):203-10. Review. French.

PMID:
17489077
10.

[Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].

Guéguen Y, Mouzat K, Ferrari L, Tissandie E, Lobaccaro JM, Batt AM, Paquet F, Voisin P, Aigueperse J, Gourmelon P, Souidi M.

Ann Biol Clin (Paris). 2006 Nov-Dec;64(6):535-48. Review. French.

11.

Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort.

Gambier N, Marteau JB, Batt AM, Marie B, Thompson A, Siest G, Foernzler D, Visvikis-Siest S.

J Hypertens. 2006 Nov;24(11):2199-205.

PMID:
17053541
12.

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

Eur J Pharmacol. 2005 Dec 19;527(1-3):1-22. Epub 2005 Nov 28. Review.

PMID:
16316654
13.

Down-regulation of astroglial CYP2C, glucocorticoid receptor and constitutive androstane receptor genes in response to cocaine in human U373 MG astrocytoma cells.

Malaplate-Armand C, Ferrari L, Masson C, Visvikis-Siest S, Lambert H, Batt AM.

Toxicol Lett. 2005 Dec 15;159(3):203-11. Epub 2005 Sep 26.

PMID:
16188404
14.

Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.

Gambier N, Batt AM, Marie B, Pfister M, Siest G, Visvikis-Siest S.

Pharmacogenomics J. 2005;5(4):271-5.

PMID:
15940289
15.

Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells.

Malaplate-Armand C, Becuwe P, Ferrari L, Masson C, Dauça M, Visvikis S, Lambert H, Batt AM.

Neuropharmacology. 2005 Apr;48(5):673-84.

PMID:
15814102
16.

[Dyslipidaemia and its management after immunosuppressive treatment].

Gueguen Y, Ferrari L, Batt AM.

Therapie. 2004 Jul-Aug;59(4):463-9. Review. French.

PMID:
15559550
17.

[Astrocytic cytochromes p450: an enzyme subfamily critical for brain metabolism and neuroprotection].

Malaplate-Armand C, Leininger-Muller B, Batt AM.

Rev Neurol (Paris). 2004 Jul;160(6-7):651-8. Review. French.

PMID:
15247853
18.

Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: linkage with varicosis.

Bertrand-Thiebault C, Ferrari L, Boutherin-Falson O, Kockx M, Desquand-Billiald S, Fichelle JM, Nottin R, Renaud JF, Batt AM, Visvikis S.

Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):295-301.

PMID:
15191401
19.

[Cytochromes P450, vascular tone varicosis].

Bertrand C, Batt AM.

Ann Pharm Fr. 2003 Jul;61(4):234-42. Review. French.

PMID:
12843956
20.

Pharmacogenomics of drugs affecting the cardiovascular system.

Siest G, Ferrari L, Accaoui MJ, Batt AM, Visvikis S.

Clin Chem Lab Med. 2003 Apr;41(4):590-9. Review.

PMID:
12747607
21.

Ethical issues: should we give the predictive genetic profile to the citizens?

Dembinska-Kiec A, Madan T, Batt AM, Vincent-Viry M, Schmitz G, Van Helden PD, Poulis P, Walter JE, Naskalski J, Loukopoulos D, Baranova H.

Clin Chem Lab Med. 2003 Apr;41(4):559-63. No abstract available.

PMID:
12747603
22.

Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1beta effect and protection by N-acetylcysteine.

Malaplate-Armand C, Ferrari L, Masson C, Siest G, Batt AM.

Toxicol Lett. 2003 Mar 3;138(3):243-51.

PMID:
12565201
23.

Control of apolipoprotein E secretion by 25-hydroxycholesterol and proinflammatory cytokines in the human astrocytoma cell line CCF-STTG1.

Gueguen Y, Bertrand P, Ferrari L, Batt AM, Siest G.

Cell Biol Toxicol. 2001;17(3):191-9.

PMID:
11693580
24.

U373-MG response to interleukin-1beta-induced oxidative stress.

Malaplate-Armand C, Gueguen Y, Bertrand P, Ferrari L, Batt AM.

Cell Biol Toxicol. 2000;16(3):155-63.

PMID:
11032359
25.

Intracellular distribution of tamoxifen in resistant human breast adenocarcinoma cells using tamoxifen-eosin association.

Bachmann N, Barberi-Heyob M, Bour C, Parache RM, Guillemin F, Batt AM, Merlin JL.

Cell Biol Toxicol. 1998 Dec;14(6):429-35.

PMID:
9879935
26.

Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1beta, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes.

Parmentier JH, Schohn H, Bronner M, Ferrari L, Batt AM, Dauça M, Kremers P.

Biochem Pharmacol. 1997 Oct 15;54(8):889-98.

PMID:
9354589
27.

A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients.

Boissonnat P, de Lorgeril M, Perroux V, Salen P, Batt AM, Barthelemy JC, Brouard R, Serres E, Delaye J.

Eur J Clin Pharmacol. 1997;53(1):39-45.

PMID:
9349928
28.
29.

[Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

Bachmann-Moisson N, Barberi-Heyob M, Merlin JL, Ledrich ML, Batt AM, Guillemin F.

Bull Cancer. 1996 Oct;83(10):808-15. Review. French.

PMID:
8952630
30.

Manifestations of chemically induced liver damage.

Batt AM, Ferrari L.

Clin Chem. 1995 Dec;41(12 Pt 2):1882-7. Review.

31.

Human cell lines in pharmacotoxicology. An introduction to a panel discussion.

Batt AM, Ferrari L, Abid A, Sabolović N.

Cell Biol Toxicol. 1995 Aug;11(3-4):179-85. Review.

PMID:
8564648
32.

Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.

Batt AM, Magdalou J, Vincent-Viry M, Ouzzine M, Fournel-Gigleux S, Galteau MM, Siest G.

Clin Chim Acta. 1994 May;226(2):171-90. Review.

PMID:
7923812
33.

[Induction and repression of cytochromes P450. In vivo and in vitro approach].

Batt AM, Strazielle N, Siegst G.

Therapie. 1993 Nov-Dec;48(6):527-36. Review. French.

PMID:
8091339
34.

Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.

Jayyosi Z, Villoutreix J, Ziegler JM, Batt AM, De Maack F, Siest G, Thomas PE.

Drug Metab Dispos. 1993 Sep-Oct;21(5):939-45.

PMID:
7902259
35.

Repression of cytochrome P450 by cytokines: IL-1 beta counteracts clofibric acid induction of CYP4A in cultured fetal rat hepatocytes.

Parmentier JH, Kremers P, Ferrari L, Batt AM, Gielen JE, Siest G.

Cell Biol Toxicol. 1993 Jul-Sep;9(3):307-13.

PMID:
8299008
36.
37.

Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.

Ferrari L, Jouzeau JY, Gillet P, Herber R, Fener P, Batt AM, Netter P.

J Pharmacol Exp Ther. 1993 Feb;264(2):1012-20.

PMID:
8437102
38.

Enzyme induction by drugs and toxins.

Batt AM, Siest G, Magdalou J, Galteau MM.

Clin Chim Acta. 1992 Jul 31;209(1-2):109-21. Review.

PMID:
1395033
39.

Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat.

Chen YL, Florentin I, Batt AM, Ferrari L, Giroud JP, Chauvelot-Moachon L.

Biochem Pharmacol. 1992 Jul 7;44(1):137-48.

PMID:
1632828
40.

Differential effects of human recombinant interleukin-1 beta on cytochrome P-450-dependent activities in cultured fetal rat hepatocytes.

Ferrari L, Kremers P, Batt AM, Gielen JE, Siest G.

Drug Metab Dispos. 1992 May-Jun;20(3):407-12.

PMID:
1355716
41.

Effects of RP 52028 and phenobarbital on mRNA levels of inducible and constitutive sex-specific cytochrome P450 isozymes in rat liver.

Strazielle N, Totis M, Herber R, Wellman M, Batt AM, Siest G.

Biochem Pharmacol. 1991 Aug 8;42(5):1053-60.

PMID:
1872892
42.

Characterization of pig liver purified cytochrome P-450 isoenzymes for ochratoxin A metabolism studies.

Oster T, Jayyosi Z, Creppy EE, el Amri HS, Batt AM.

Toxicol Lett. 1991 Jul;57(2):203-14.

PMID:
1853365
43.

Influence of muramyl dipeptide on established experimental arthritis in rats.

Jouzeau JY, Drelon E, Gillet P, Bannwarth B, Fener P, Charrière G, Payan E, Chauvelot-Moachon L, Batt AM, Floquet J, et al.

Agents Actions Suppl. 1991;32:191-5.

PMID:
2069088
44.

[Inhibition of cytochromes P-450. Biochemical mechanisms and possible therapeutic consequences. I--Inactivation by formation of reversible complexes].

Jayyosi Z, Livertoux MH, Batt AM, Siest G.

J Toxicol Clin Exp. 1991 Jan-Feb;11(1):9-30. Review. French.

PMID:
1875300
45.

Induction of UDP-glucuronosyltransferase isozymes in male and female rat liver microsomes by an isoquinoleine derivative (52028 RP).

Totis M, Magdalou J, Fournel-Gigleux S, Batt AM, Siest G.

Biochem Pharmacol. 1989 Oct 15;38(20):3634-8. No abstract available.

PMID:
2510737
46.

[Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)].

Freche JP, Decolin D, Siest JP, Batt AM, Panis-Rouzier R, Siest G.

Therapie. 1989 Sep-Oct;44(5):327-30. French.

PMID:
2573163
47.

Induction of liver microsomal cytochrome P-450 isozymes by 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide.

Totis M, Kremers P, Batt AM, Van Cantfort J, Siest G, Gielen J.

Xenobiotica. 1989 Aug;19(8):857-66.

PMID:
2815828
48.

Preparative high-performance liquid chromatographic method for the 2-hydroxy metabolite of carpipramine, excreted by isolated perfused liver.

Schmitt P, Batt AM, Decouvelaere B, Gaillot J, Siest G.

J Chromatogr. 1989 Jul 21;491(2):495-500. No abstract available.

PMID:
2808634
49.

[Changes of plasma and tissue gamma-glutamyltransferase under the influence of drugs].

Siest G, Strazielle N, L'Hôte H, Wellman M, Bagrel D, Batt AM, Schiele F, Galteau MM.

Therapie. 1989 Jan-Feb;44(1):19-28. Review. French.

PMID:
2567537
50.

Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines.

Rolin S, Souhaili-el Amri H, Batt AM, Levy M, Bagrel D, Siest G.

Cell Biol Toxicol. 1989 Jan;5(1):1-14.

PMID:
2563953

Supplemental Content

Support Center